Weighing Treatment Risks Versus Benefits Ultimately a Patient Calculation

Maurie Markman, MD
Published: Wednesday, Mar 14, 2018
Maurie Markman, MD

Maurie Markman, MD
One of the cardinal principles of modern medicine, as practiced in the United States, is active participation by patients—and often their families—in the process of clinical decision making. Of course, there are rational and practical limits to this process. For example, patients generally will not be asked to decide what type of sutures to use in a surgical procedure or the specific antibiotic to be employed in managing an infection (except, of course, to inquire regarding the presence of prior allergic reactions).

Therefore, the question is whether the unequivocal improvement in clinical outcome for the overall population associated with the aggressive therapy is justified, considering that there is a 1 in 20 chance of treatment-related mortality in this carefully selected and managed patient group. Of course, there is no single correct answer, just a decision that should be made by the individual patient.

Interpreting Oncology Data

Turning to the realm of oncology, it is not difficult to find examples of study results in which individual patients may legitimately reach different conclusions regarding the interpretation of trial outcomes, including concerns about the risk of severe morbidity or treatment-related mortality versus the realistic potential for improved survival.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Therapies for Patients With ALK-Positive Lung Cancers: More Options…More Decisions…Better OutcomesAug 30, 20191.5
Community Practice Connections™: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your PatientsAug 30, 20191.5
Publication Bottom Border
Border Publication
x